Gene-expression profiling has identified five molecular subtypes of breast cancer, known as luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, claudin-low, and basal-like, with inter-subtype differences in incidence, survival, and treatment response [1,2,3,4,5]. The gene discussed is ERBB2; the disease is breast carcinoma.